Cipla share price
You have to be logged in to add this to Watchlist.- ₹1,281.45(-1.34%)March 17, 2026 15:48:07 PM IST
- NSE
- BSE
- Vol : 2.06 M (NSE + BSE)Last 20 day avg : 1.60 M
Cipla is trading -1.34% lower at Rs 1,281.45 as compared to its last closing price. Cipla has been trading in the price range of 1,311.25 & 1,275.65. Cipla has given -13.98% in this year & -1.89% in the last 5 days. Cipla has TTM P/E ratio 26.84 as compared to the sector P/E of 23.34.There are 37 analysts who have initiated coverage on Cipla. There are 5 analysts who have given it a strong buy rating & 15 analysts have given it a buy rating. 7 analysts have given the stock a sell rating.The company posted a net profit of 675.80 Crores in its last quarter.Listed peers of Cipla include Torrent Pharmaceuticals (1.01%), Sun Pharmaceutical Industries (0.46%), Lupin (0.30%).The Mutual Fund holding in Cipla was at 19.21% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Cipla was at 23.93% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 17, 2026, 04:06 PM UTC
- BetaLow volatility0.56Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldInline with the industry0.99Annual dividends as a percentage of the stock price.
- P/BLower than historical values3.40The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values23.37Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.84The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 4,305.95 | 1.01 | 1,45,727.06 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,790.70 | 0.46 | 4,30,738.26 | 36.24 | 5.77 | 0.92 | 0.50 |
| Lupin | Bullish | 2,297.00 | 0.30 | 1,05,159.61 | 28.78 | 5.59 | 0.57 | 11.80 |
| Dr Reddy's Laboratories | Neutral | 1,281.55 | 0.51 | 1,06,958.67 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bearish | 6,094.00 | 0.31 | 1,62,563.29 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE059A01026
- BSE Code500087
- NSE CodeCIPLA
Cipla is trading at 1281.45 as on Tue Mar 17 2026 10:18:07. This is -1.34% lower as compared to its previous closing price of 1298.80.
The market capitalization of Cipla is 103513.05 Cr as on Tue Mar 17 2026 10:18:07.
The average broker rating on Cipla is Hold. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 15 analysts have given a buy rating
- 8 analysts have given a hold rating
- 7 analysts have given a sell rating
- 2 analysts have given a strong sell rating
The 52 wk high for Cipla is 1672.20 whereas the 52 wk low is 1283.00
Cipla can be analyzed on the following key metrics -
- TTM P/E: 26.84
- Sector P/E: 23.34
- Dividend Yield: 1.00%
- D/E ratio: -
Cipla reported a net profit of 5272.52 Cr in 2025.
The Mutual Fund Shareholding was 19.21% at the end of 31 Dec 2025.